These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6499233)

  • 21. Growth hormone and prolactin responses to bolus and sustained infusions of GRH-1-40-OH in man.
    Goldman JA; Molitch ME; Thorner MO; Vale W; Rivier J; Reichlin S
    J Endocrinol Invest; 1987 Aug; 10(4):397-406. PubMed ID: 3119697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium and calcium-antagonistic effects on prolactin and growth hormone responses to thyrotropin-releasing hormone and L-dopa in man.
    Röjdmark S; Andersson DE; Sundblad L
    J Clin Endocrinol Metab; 1981 Sep; 53(3):594-8. PubMed ID: 6790560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man.
    Arvat E; Maccagno B; Ramunni J; Gianotti L; Di Vito L; Deghenghi R; Camanni F; Ghigo E
    J Endocrinol Invest; 1997 Mar; 20(3):122-7. PubMed ID: 9186817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects.
    Hanew K; Tanaka A; Utsumi A; Sugawara A; Abe K
    J Clin Endocrinol Metab; 1996 May; 81(5):1952-5. PubMed ID: 8626863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of the histaminergic system on opiate-induced neurosecretion and behaviour.
    Duka T; Hoehe M; Doenicke A; Stephan U; Matussek N
    Psychoneuroendocrinology; 1987; 12(4):271-80. PubMed ID: 3659227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of nitric oxide in the interferon-gamma-induced inhibition of growth hormone and prolactin secretion in anterior pituitary cell cultures.
    Vankelecom H; Matthys P; Denef C
    Mol Cell Endocrinol; 1997 May; 129(2):157-67. PubMed ID: 9202399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of GRF(1-40) and domperidone on GH secretion in normal man.
    Giusti M; Mazzocchi G; Sessarego P; Mignone D; Lomeo A; Monachesi M; Giordano G
    Clin Endocrinol (Oxf); 1984 Oct; 21(4):339-43. PubMed ID: 6439434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naloxone inhibits exercise-induced release of PRL and GH in athletes.
    Moretti C; Fabbri A; Gnessi L; Cappa M; Calzolari A; Fraioli F; Grossman A; Besser GM
    Clin Endocrinol (Oxf); 1983 Feb; 18(2):135-8. PubMed ID: 6851196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of l-DOPA and sulpiride on growth hormone secretion at different injection times in Holstein steers.
    Kasuya E; Sutoh M; Yayou KI
    Anim Sci J; 2017 Nov; 88(11):1842-1848. PubMed ID: 28585780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.
    Hanew K; Aida M; Tano T; Yoshinaga K
    Tohoku J Exp Med; 1977 Mar; 121(3):197-206. PubMed ID: 404727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pooled prolactin measurements in the evaluation of short children.
    Shulman DI; Hu CS; Root AW; Bercu BB
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1261-7. PubMed ID: 2511222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histaminergic regulation of prolactin secretion: dose-response relationship and possible involvement of the dopaminergic system.
    Knigge U; Thuesen B; Christiansen PM
    J Clin Endocrinol Metab; 1986 Mar; 62(3):491-6. PubMed ID: 3944233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of papaverine to alter L-dopa-influenced GH and PRL secretion.
    Cooper DS; Jacobs LS
    J Clin Endocrinol Metab; 1977 Mar; 44(3):585-7. PubMed ID: 838852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy.
    Popovic V; Simic M; Ilic L; Micic D; Damjanovic S; Djurovic M; Obradovic S; Dieguez C; Casanueva F
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):103-8. PubMed ID: 9509075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the role of histamine in human pituitary function.
    Carlson HE; Chang RJ
    Clin Endocrinol (Oxf); 1980 May; 12(5):461-6. PubMed ID: 6775851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA; Frohman LA
    J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
    González LC; Pinilla L; Tena-Sempere M; Aguilar E
    J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue.
    Peracchi M; Molteni N; Cantalamessa L; Bardella MT; Peracchi G; Orsatti A; Faggioli P; Bianchi PA
    Am J Gastroenterol; 1992 May; 87(5):580-3. PubMed ID: 1595643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Responses of growth hormone and prolactin to L-Dopa in women with polycystic ovarian syndrome].
    Wu X; Gu Q; Su Y
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):489-91. PubMed ID: 9639745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.